Literature DB >> 26864034

Low-Affinity Memory CD8+ T Cells Mediate Robust Heterologous Immunity.

Scott M Krummey1, Ryan J Martinez2, Rakieb Andargachew2, Danya Liu1, Maylene Wagener1, Jacob E Kohlmeier2, Brian D Evavold2, Christian P Larsen1, Mandy L Ford3.   

Abstract

Heterologous immunity is recognized as a significant barrier to transplant tolerance. Whereas it has been established that pathogen-elicited memory T cells can have high or low affinity for cross-reactive allogeneic peptide-MHC, the role of TCR affinity during heterologous immunity has not been explored. We established a model with which to investigate the impact of TCR-priming affinity on memory T cell populations following a graft rechallenge. In contrast to high-affinity priming, low-affinity priming elicited fully differentiated memory T cells with a CD45RB(hi) status. High CD45RB status enabled robust secondary responses in vivo, as demonstrated by faster graft rejection kinetics and greater proliferative responses. CD45RB blockade prolonged graft survival in low affinity-primed mice, but not in high affinity-primed mice. Mechanistically, low affinity-primed memory CD8(+) T cells produced more IL-2 and significantly upregulated IL-2Rα expression during rechallenge. We found that CD45RB(hi) status was also a stable marker of priming affinity within polyclonal CD8(+) T cell populations. Following high-affinity rechallenge, low affinity-primed CD45RB(hi) cells became CD45RB(lo), demonstrating that CD45RB status acts as an affinity-based differentiation switch on CD8(+) T cells. Thus, these data establish a novel mechanism by which CD45 isoforms tune low affinity-primed memory CD8(+) T cells to become potent secondary effectors following heterologous rechallenge. These findings have direct implications for allogeneic heterologous immunity by demonstrating that despite a lower precursor frequency, low-affinity priming is sufficient to generate memory cells that mediate potent secondary responses against a cross-reactive graft challenge.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26864034      PMCID: PMC4779681          DOI: 10.4049/jimmunol.1500639

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

1.  The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained.

Authors:  E J Wherry; K A Puorro; A Porgador; L C Eisenlohr
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

2.  Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection.

Authors:  Benjamin D Ehst; Elizabeth Ingulli; Marc K Jenkins
Journal:  Am J Transplant       Date:  2003-11       Impact factor: 8.086

3.  Alteration in CD45RBhi/CD45RBlo T-cell ratio following CD45RB monoclonal-antibody therapy occurs by selective deletion of CD45RBhi effector cells.

Authors:  Patrick P W Luke; Jian P Deng; Catherine A O'Brien; Michelle Everest; Anne V Hall; Subrata Chakrabarti; Peta J O'Connell; Robert Zhong; Anthony M Jevnikar
Journal:  Transplantation       Date:  2003-07-27       Impact factor: 4.939

4.  Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin.

Authors:  Andrew M Intlekofer; Naofumi Takemoto; E John Wherry; Sarah A Longworth; John T Northrup; Vikram R Palanivel; Alan C Mullen; Christopher R Gasink; Susan M Kaech; Joseph D Miller; Laurent Gapin; Kenneth Ryan; Andreas P Russ; Tullia Lindsten; Jordan S Orange; Ananda W Goldrath; Rafi Ahmed; Steven L Reiner
Journal:  Nat Immunol       Date:  2005-11-06       Impact factor: 25.606

5.  Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling.

Authors:  Mark A Daniels; Emma Teixeiro; Jason Gill; Barbara Hausmann; Dominique Roubaty; Kaisa Holmberg; Guy Werlen; Georg A Holländer; Nicholas R J Gascoigne; Ed Palmer
Journal:  Nature       Date:  2006-11-01       Impact factor: 49.962

6.  Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections.

Authors:  Michael A Brehm; Thomas G Markees; Keith A Daniels; Dale L Greiner; Aldo A Rossini; Raymond M Welsh
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

7.  Expression of two T cell receptor alpha chains: dual receptor T cells.

Authors:  E Padovan; G Casorati; P Dellabona; S Meyer; M Brockhaus; A Lanzavecchia
Journal:  Science       Date:  1993-10-15       Impact factor: 47.728

8.  T cell receptor antagonist peptides induce positive selection.

Authors:  K A Hogquist; S C Jameson; W R Heath; J L Howard; M J Bevan; F R Carbone
Journal:  Cell       Date:  1994-01-14       Impact factor: 41.582

9.  Heterologous immunity provides a potent barrier to transplantation tolerance.

Authors:  Andrew B Adams; Matthew A Williams; Thomas R Jones; Nozomu Shirasugi; Megan M Durham; Susan M Kaech; E John Wherry; Thandi Onami; J Gibson Lanier; Kenneth E Kokko; Thomas C Pearson; Rafi Ahmed; Christian P Larsen
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

10.  Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

Authors:  Matthew A Williams; Aaron J Tyznik; Michael J Bevan
Journal:  Nature       Date:  2006-06-15       Impact factor: 49.962

View more
  22 in total

1.  Targeted loss of SHP1 in murine thymocytes dampens TCR signaling late in selection.

Authors:  Ryan J Martinez; Anna B Morris; Dennis K Neeld; Brian D Evavold
Journal:  Eur J Immunol       Date:  2016-09       Impact factor: 5.532

2.  Transplantation preferentially induces a KLRG-1lo CD127hi differentiation program in antigen-specific CD8+ T cells.

Authors:  Alana M Bozeman; Sonia J Laurie; Divya Haridas; Maylene E Wagener; Mandy L Ford
Journal:  Transpl Immunol       Date:  2018-06-08       Impact factor: 1.708

3.  CD45RB Status of CD8+ T Cell Memory Defines T Cell Receptor Affinity and Persistence.

Authors:  Scott M Krummey; Anna B Morris; Jesica R Jacobs; Donald J McGuire; Satomi Ando; Katherine P Tong; Weiwen Zhang; Jennifer Robertson; Sara A Guasch; Koichi Araki; Christian P Larsen; Brian D Evavold; Haydn T Kissick; Mandy L Ford
Journal:  Cell Rep       Date:  2020-02-04       Impact factor: 9.423

4.  Enhanced Requirement for TNFR2 in Graft Rejection Mediated by Low-Affinity Memory CD8+ T Cells during Heterologous Immunity.

Authors:  Scott M Krummey; Ching-Wen Chen; Sara A Guasch; Danya Liu; Maylene Wagener; Christian P Larsen; Mandy L Ford
Journal:  J Immunol       Date:  2016-08-01       Impact factor: 5.422

Review 5.  Reinterpreting recent thymic emigrant function: defective or adaptive?

Authors:  Cody A Cunningham; Eric Y Helm; Pamela J Fink
Journal:  Curr Opin Immunol       Date:  2017-12-16       Impact factor: 7.486

Review 6.  T-cell receptor affinity in the age of cancer immunotherapy.

Authors:  Michele M Hoffmann; Jill E Slansky
Journal:  Mol Carcinog       Date:  2020-05-09       Impact factor: 4.784

7.  Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell-Effector Responses.

Authors:  Michael E Birnbaum; Stephanie K Dougan; Eleanor Clancy-Thompson; Christine A Devlin; Paul M Tyler; Mariah M Servos; Lestat R Ali; Katherine S Ventre; M Aladdin Bhuiyan; Patrick T Bruck
Journal:  Cancer Immunol Res       Date:  2018-10-23       Impact factor: 11.151

8.  CD4 T Cell Affinity Diversity Is Equally Maintained during Acute and Chronic Infection.

Authors:  Rakieb Andargachew; Ryan J Martinez; Elizabeth M Kolawole; Brian D Evavold
Journal:  J Immunol       Date:  2018-05-18       Impact factor: 5.422

Review 9.  Tissue-resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders.

Authors:  Ling Chen; Zhu Shen
Journal:  Cell Mol Immunol       Date:  2019-10-08       Impact factor: 11.530

Review 10.  Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms.

Authors:  Lloyd D'Orsogna; Heleen van den Heuvel; Cees van Kooten; Sebastiaan Heidt; Frans H J Claas
Journal:  Immunogenetics       Date:  2017-07-17       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.